204 related articles for article (PubMed ID: 7523465)
21. Correlation of clinical responses with immunologic and morphologic characteristics in patients with cutaneous T-cell lymphoma treated with interferon alfa-2a.
Springer EA; Kuzel TM; Variakojis D; Kaul K; Rosen ST; Roenigk HH
J Am Acad Dermatol; 1993 Jul; 29(1):42-6. PubMed ID: 7686188
[TBL] [Abstract][Full Text] [Related]
22. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
23. [Cutaneous lymphomas].
Schad K; Baumann Conzett K; Cozzio A
Ther Umsch; 2010 Sep; 67(9):453-64. PubMed ID: 20806174
[TBL] [Abstract][Full Text] [Related]
24. Erythematous atrophic plaque in the inguinal fold.
Graves MS; Orr WB; Anand D; Davis LS
Cutis; 2016 May; 97(5):334;341;342. PubMed ID: 27274547
[No Abstract] [Full Text] [Related]
25. U.K. national audit of extracorporeal photopheresis in cutaneous T-cell lymphoma.
Sanyal S; Child F; Alfred A; Callaghan T; Alband N; Whittaker S; Cowan R; Parry E; Robinson S; Dunnill MGS; Wain M; Morris S; Malladi R; Tahir S; Howles A; Arumainathan A; Azurdia R; Grant-Casey J; Matin RN; Gilson D; Howell C; El-Gheriani K; Taylor P; Scarisbrick J
Br J Dermatol; 2018 Feb; 178(2):569-570. PubMed ID: 28782100
[No Abstract] [Full Text] [Related]
26. [Therapeutic perspectives of cutaneous T-cell lymphoma].
Sassolas B; Battistella M
Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H19-22. PubMed ID: 21703466
[No Abstract] [Full Text] [Related]
27. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
[TBL] [Abstract][Full Text] [Related]
28. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
Geskin L
Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
[TBL] [Abstract][Full Text] [Related]
29. Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2.
Rook AH; Kuzel TM; Olsen EA
Hematol Oncol Clin North Am; 2003 Dec; 17(6):1435-48, ix. PubMed ID: 14710894
[TBL] [Abstract][Full Text] [Related]
30. [Therapy of cutaneous T-cell lymphomas].
Rappersberger K; Ortel B; Forstinger C; Wolff K
Wien Klin Wochenschr; 1994; 106(10):300-8. PubMed ID: 8053197
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous T-cell lymphoma and cutaneous graft-versus-host disease. Two indications for photopheresis in dermatology.
Girardi M; Heald PW
Dermatol Clin; 2000 Jul; 18(3):417-23, viii. PubMed ID: 10943537
[TBL] [Abstract][Full Text] [Related]
32. Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution.
Suchin KR; Cucchiara AJ; Gottleib SL; Wolfe JT; DeNardo BJ; Macey WH; Bromley PG; Vittorio CC; Rook AH
Arch Dermatol; 2002 Aug; 138(8):1054-60. PubMed ID: 12164743
[TBL] [Abstract][Full Text] [Related]
33. The therapeutic role of interferons and monoclonal antibodies in cutaneous T-cell lymphomas.
Bunn PA; Norris DA
J Invest Dermatol; 1990 Dec; 95(6 Suppl):209S-212S. PubMed ID: 1701807
[No Abstract] [Full Text] [Related]
34. Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms.
Dummer R; Foss F; Dreno B; Bagot M
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S26-32. PubMed ID: 16516673
[TBL] [Abstract][Full Text] [Related]
35. Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantation.
Schlaak M; Kurschat P; Shimabukuro-Vornhagen A; Scheid C; Chemnitz J; Stadler R; von Bergwelt-Baildon M; Theurich S
Transpl Immunol; 2011 Sep; 25(2-3):163-6. PubMed ID: 21745569
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
37. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
Atta M; Papanicolaou N; Tsirigotis P
Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
[TBL] [Abstract][Full Text] [Related]
38. [Cutaneous lymphoma].
Beyeler M; Burg G; Dummer R
Hautarzt; 2004 Oct; 55(10):1005-16; quiz 1017. PubMed ID: 15349694
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic applications of photopheresis.
Rook AH; Cohen JH; Lessin SR; Vowels BR
Dermatol Clin; 1993 Apr; 11(2):339-47. PubMed ID: 8477547
[TBL] [Abstract][Full Text] [Related]
40. Future perspectives in the treatment of cutaneous T-cell lymphoma (CTCL).
Dummer R
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S33-6. PubMed ID: 16516674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
